MedTrace Logo

Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM

NCT03741660 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-11-15

No results posted yet for this study

Summary

To examine whether Konjac-mannan fiber improves metabolic control measured by glycemia, lipidemia, and blood pressure in individuals with type-2 diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

konjac glucomannan

Konjac-mannan fiber-enriched biscuits (0.7 g/412KJ \[100kcal\] of glucommanan)

DIETARY_SUPPLEMENT

wheat bran

Wheat bran (hard red wheat bran) fiber enriched biscuits

Sponsors & Collaborators

  • Dicofarm

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-01-31
Primary Completion
1992-06-30
Completion
1998-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741660 on ClinicalTrials.gov